These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 12719780)
1. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations. Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780 [TBL] [Abstract][Full Text] [Related]
2. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]
3. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm. Hosaka A; Miyata T; Aramoto H; Shigematsu H; Nakazawa T; Okamoto H; Shigematsu K; Nagawa H J Vasc Surg; 2005 Aug; 42(2):200-5. PubMed ID: 16102614 [TBL] [Abstract][Full Text] [Related]
4. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232 [TBL] [Abstract][Full Text] [Related]
5. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398 [TBL] [Abstract][Full Text] [Related]
6. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Horan JT; Francis CW Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic molecular markers before the onset of disseminated intravascular coagulation. Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100 [TBL] [Abstract][Full Text] [Related]
9. Soluble fibrin augments spreading of fibroblasts by providing RGD sequences of fibrinogen in soluble fibrin. Yang W; Wu B; Asakura S; Kohno I; Matsuda M Thromb Res; 2004; 114(4):293-300. PubMed ID: 15381393 [TBL] [Abstract][Full Text] [Related]
10. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]
11. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma. Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656 [TBL] [Abstract][Full Text] [Related]
13. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [TBL] [Abstract][Full Text] [Related]
14. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623 [TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490 [TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen. Thiel W; Delvos U; Müller-Berghaus G Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091 [TBL] [Abstract][Full Text] [Related]
17. [Molecular marker for detecting hypercoagulable state]. Magari Y; Mizunaga S; Ito M; Shibata T; Ito H Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279 [TBL] [Abstract][Full Text] [Related]
18. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis. Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575 [TBL] [Abstract][Full Text] [Related]